Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to $3.6 billion.

  • Dexcom's Total Liabilities fell 1798.31% to $3.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.6 billion, marking a year-over-year decrease of 1798.31%. This contributed to the annual value of $3.6 billion for FY2025, which is 1798.31% down from last year.
  • Per Dexcom's latest filing, its Total Liabilities stood at $3.6 billion for Q4 2025, which was down 1798.31% from $4.8 billion recorded in Q3 2025.
  • In the past 5 years, Dexcom's Total Liabilities registered a high of $4.8 billion during Q3 2025, and its lowest value of $2.5 billion during Q1 2021.
  • Moreover, its 5-year median value for Total Liabilities was $3.9 billion (2023), whereas its average is $3.7 billion.
  • Per our database at Business Quant, Dexcom's Total Liabilities skyrocketed by 6430.55% in 2021 and then plummeted by 1798.31% in 2025.
  • Dexcom's Total Liabilities (Quarter) stood at $2.9 billion in 2021, then rose by 12.75% to $3.3 billion in 2022, then grew by 28.71% to $4.2 billion in 2023, then grew by 4.43% to $4.4 billion in 2024, then decreased by 17.98% to $3.6 billion in 2025.
  • Its last three reported values are $3.6 billion in Q4 2025, $4.8 billion for Q3 2025, and $4.8 billion during Q2 2025.